The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting provided a platform for interaction and exchange among basic scientists and clinicians in breast cancer. Highlights from this hybrid meeting include the latest Phase III data for the use of SERDs for HR+/HER2- disease, updates on the use of IO in TNBC as well as the importance of tackling disparities in breast cancer treatment and survival outcomes.
View all videos

SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting
07–10 December 2021 | San Antonio, TX

📢It’s #WorldCancerResearchDay!

➡️Head over to http://VJOncology.com to explore exciting updates in the latest clinical trials!

⭐Whilst you’re there, make sure to check out some of the cutting-edge research presented at #ESMO22 just last week!

@myESMO @VJOncology

📢http://VJOncology.com has roundtable discussions featuring leading experts of #LungCancer, #BreastCancer, and more!

⭐Listen as they discuss key issues in cancer research in light of #WorldCancerResearchDay

➡️http://ow.ly/ixbX50KQh5s⬅️

#Oncology #VJSession @VJOncology

🎥 @david_tougeron of Poitiers University Hospital discusses DURIGAST: 2L FOLFIRI plus durvalumab plus tremelimumab in gastric or GEJ cancer

Watch: 👉http://ow.ly/RBmH50KQzCP👈

@myESMO #ESMO22

📢Check out some of the highlights from ASCO 2022 over at http://VJOncology.com, including key updates in clinical trials generating improved outcomes for patients worldwide.

📖Read here ➡️http://ow.ly/PO4s50KQgfE⬅️

#WorldCancerResearchDay @ASCO @VJOncology #ASCO22 #Oncology

We’re here to bring you the highlights of what experts have been discussing on the second day of #NACLC22! 🙌

Check out http://VJOncology.com to discover more about what experts have discussed so far in the field of #LungCancer.

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More

SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting
07–10 December 2021 | San Antonio, TX
The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting provided a platform for interaction and exchange among basic scientists and clinicians in breast cancer. Highlights from this hybrid meeting include the latest Phase III data for the use of SERDs for HR+/HER2- disease, updates on the use of IO in TNBC as well as the importance of tackling disparities in breast cancer treatment and survival outcomes.
View all videos

📢It’s #WorldCancerResearchDay!

➡️Head over to http://VJOncology.com to explore exciting updates in the latest clinical trials!

⭐Whilst you’re there, make sure to check out some of the cutting-edge research presented at #ESMO22 just last week!

@myESMO @VJOncology

📢http://VJOncology.com has roundtable discussions featuring leading experts of #LungCancer, #BreastCancer, and more!

⭐Listen as they discuss key issues in cancer research in light of #WorldCancerResearchDay

➡️http://ow.ly/ixbX50KQh5s⬅️

#Oncology #VJSession @VJOncology

🎥 @david_tougeron of Poitiers University Hospital discusses DURIGAST: 2L FOLFIRI plus durvalumab plus tremelimumab in gastric or GEJ cancer

Watch: 👉http://ow.ly/RBmH50KQzCP👈

@myESMO #ESMO22

📢Check out some of the highlights from ASCO 2022 over at http://VJOncology.com, including key updates in clinical trials generating improved outcomes for patients worldwide.

📖Read here ➡️http://ow.ly/PO4s50KQgfE⬅️

#WorldCancerResearchDay @ASCO @VJOncology #ASCO22 #Oncology

We’re here to bring you the highlights of what experts have been discussing on the second day of #NACLC22! 🙌

Check out http://VJOncology.com to discover more about what experts have discussed so far in the field of #LungCancer.

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter